Stay updated on Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial
Sign up to get notified when there's something new on the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page.

Latest updates to the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page
- Check6 days agoChange DetectedAdministrative updates were made to the study record, adding update dates of 2026-03-24 and 2026-03-25 and removing 2026-03-18 and 2026-03-19. These changes do not alter the study’s core content, eligibility, or outcomes.SummaryDifference0.1%

- Check13 days agoChange DetectedPage revision updated to v3.5.0 with new dates (2026-03-18, 2026-03-19) and removal of earlier updates (2026-03-11, 2026-03-12).SummaryDifference0.2%

- Check21 days agoChange DetectedThe page revision updated to v3.4.3 with new update dates (2026-03-11 and 2026-03-12) added and earlier revision/date entries (v3.4.2, 2026-03-04, 2026-03-05) removed.SummaryDifference0.2%

- Check28 days agoChange DetectedThe study record was updated with new post and submission dates (Last Update Posted 2026-03-05; 2026-03-04) to reflect recent edits to the trial details.SummaryDifference0.1%

- Check35 days agoChange DetectedStudy record updates were made on 2026-02-24 and 2026-02-25, refining the study details and related sections (timelines, locations, and eligibility/plan descriptions).SummaryDifference0.2%

- Check50 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-lapse notice and Revision: v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page.